Loading into and electro-stimulated release of peptides and proteins from chondroitin 4-sulphate hydrogels.
Chondroitin 4-sulphate (CS) hydrogels were examined as potential matrices for the electro-controlled delivery of peptides and proteins. A CS hydrogel, cross-linked with ethylene glycol diglycidyl ether, and with a swelling ratio of 20, was used to study the influence of molecular size and shape of guest molecules on loading and release rates. Three positively charged molecules of different molecular weights (vasopressin MW 1084, aprotinin MW 6512 and lysozyme MW 14,400), and one negatively charged protein (bovine serum albumin MW 67,000) were used as model solutes. The hydrogels were loaded by equilibrium swelling. As a result, the three positively charged peptide and proteins were found to be concentrated in the gels, most likely due to ionic attraction between the negative charges in the gel polymeric backbone and the positively charged solutes. No such concentration of solute in the gel was seen for the negatively charged albumin. The latter is presumably loaded passively by diffusing in the water phase of the gel. The loading efficiency (indicated by the loading rate and the total amount of solute loaded in the gel) was found to increase with decreasing molecular size of solute. Electro-stimulated release of the loaded peptide and proteins was followed for 3 h during which an electric field was applied in pulses of 5 V (pulse duration and pulse interval were both of 20 min). The release of lysozyme and aprotinin from CS hydrogels responded to electrical pulses. On the other hand, vasopressin and albumin were largely released by passive diffusion and their release could not be electrically controlled. This work shows that the size of the guest molecule is an important parameter when electrically-stimulated drug release is desired, but further work obviously needs to be carried out with a larger range of molecular weights and conformations.
Jensen
Malene
M
The Royal Danish School of Pharmacy, Copenhagen, Denmark.
Birch Hansen
Pernille
P
Murdan
Sudaxshina
S
Frokjaer
Sven
S
Florence
Alexander T
AT
D007611:Aprotinin / Q000737:chemistry / Q000378:metabolism; D002626:Chemistry, Pharmaceutical; D002809:Chondroitin Sulfates; D003692:Delayed-Action Preparations / Q000737:chemistry / Q000378:metabolism; D004058:Diffusion; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods; D004563:Electrochemistry; D020100:Hydrogels / Q000737:chemistry* / Q000378:metabolism*; D015394:Molecular Structure; D008970:Molecular Weight; D009113:Muramidase / Q000737:chemistry / Q000378:metabolism; D011506:Proteins / Q000737:chemistry / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000378:metabolism; D014667:Vasopressins / Q000737:chemistry / Q000378:metabolism
D003692:Delayed-Action Preparations; D004337:Drug Carriers; D020100:Hydrogels; D011506:Proteins; D014667:Vasopressins; D012710:Serum Albumin, Bovine; D002809:Chondroitin Sulfates; D007611:Aprotinin; D009113:Muramidase